Abstract
To the Editor: Mohs micrographic surgery (MMS) is indicated for the treatment of high-risk basal cell carcinoma (BCC) based on superior long-term outcomes compared to wide local excision (WLE).1,2 Factors that may predict poor outcomes include tumor diameter of ≥2 cm, head and neck location, deep invasion, recurrence, aggressive histologic subtype, and perineural invasion.3,4 The American Joint Committee on Cancer (AJCC, 8th edition) and the Brigham and Women Hospital (BWH) staging systems have incorporated some of these parameters to risk-stratify BCC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
